|
|
Science Sparks @ ACTREC
|
14 March 2022 |
Vol. No. 11; Issue No. 517 |
|
Publications
|
1. Miriyala R, Mahantshetty U, Maheshwari A, Gupta S (2022). Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future. International Journal of Gynecological Cancer 32(3):260-265.
2. Chopra S, Ranjan N, Mittal P (2022). Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future. International Journal of Gynecological Cancer. 32(3):225-230.
3. Swamidas J, Jain J, Nesvacil N, Tanderup K, Kirisits C, Schmid M, Agarwal P, Joshi K, Naga P, Ranjan Khadanga C, Gudi S, Gurram L, Chopra S, Mahantshetty U. Dosimetric impact of target definition in brachytherapy for cervical cancer - Computed tomography and trans rectal ultrasound versus magnetic resonance imaging. Physics & Imaging in Radiation Oncology. 21:126-133.
4. Hande V, Chopra S, Kalra B, Abdel-Wahab M, Kannan S, Tanderup K, Grover S, Zubizarreta E, Rubio JAP(2022). Point-A vsVolume-based brachytherapy for the treatment of cervix cancer: A meta-analysis. Radiotherapy Oncology
5. Mishra A, Janu A, Trivedi K, Shetty P, Singh V, Moiyadi A (2022). Subpial en bloc resection improves extent of resection in infiltrating gliomas – a propensity matched comparative cohort analysis. Clinical Neurology and Neurosurgery.
6. Desai S, Dharavath B, Manavalan S, Rane A, Redhu A, Sunder R, Butle A, Mishra R, Joshi A, Togar T, Apte S, Bala P, Chandrani P, Chopra S, Bashyam M, Banerjee A, Prabhash K, Nair S, Dutt A(2022). Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cance., NAR Cancer. 4(1): zcac006.
7. Jha A, Ravichandran G, De A, Srivastava R (2022).NANOTORRID®: Graphene-like properties of a gold/polypropylene nanocomposite and its photothermal application. Journal of Materials Research.
8. Krishnatry R, Gudi S, Siwach A, Patil A, Rajesh KR, Shekhar H, Sutar V, Chatterjee A, Goda J, Jalali R, Gupta T (2022). Impact of immobilisation and image guidance protocol on planning target volume margins for supine craniospinal irradiation. Reports of Practical Oncology and Radiotherapy.
Thesis
Nazia Chaudhary. 2022. Characterization of pathways that promotes tumorigenesis, radio and chemo resistance upon Plakophilin3 loss. (HBNI NO.: LIFE09201504013). (Guide: Dr Sorab Dalal)
|
|
|
Interesting Reads
|
Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. J Clin Oncol. 40(8):876-883, 2022.
|
|
Legends of Science
|
|
Chandrima Shaha
Dr. Chandrima Shaha, an Indian biologist, earned her Ph.D. from the Indian Institute of Chemical Biology, Calcutta (then the Indian Institute of Experimental Medicine). She made significant contributions in understanding cellular defense mechanisms from oxidative stress and modalities of cell death in a multicellular model of mammalian germ cells and a unicellular model of a protozoan parasite. She is currently holding the President Chair of the Indian National Science Academy. Shaha served as a Member of the Task Force on Human Genetics and Genome Analysis, Department of Biotechnology. In 1992, Dr. Shaha received the Shakuntala Amirchand Award of ICMR. She also received Special Award for the 50th Anniversary of DNA Double Helix Discovery (2003) for her outstanding contributions in understanding Cell Death Processes in different Model Organisms.
|
|
|
|
Somadatta Sinha
Dr. Sinha obtained her Ph.D. from the School of Environmental Sciences, Jawaharlal Nehru University, New Delhi. Her research focussed on theoretical biology, nonlinear dynamics, and complex systems, intending to understand the logic and design of biological processes. Her research work also involved analyzing epidemiological data of infectious diseases, studying host-parasite evolution using genomic data and computational modeling, and graph theory to understand macroscopic properties of intracellular networks. She worked as a Scientist at CCMB, Hyderabad, from 1983 to 2011, became a Professor, and later a visiting Professor at IISER, Mohali. She received the J C Bose National Fellowship (2012) by the DST and received the National Women Bioscientist (senior) Award in 2013 by the DBT.
|
|
|
|
|
Do You Know?
In 2007, a large clinical trial showed that adding arsenic trioxide ( Trisenox) to the standard treatment for acute promyelocytic leukemia (APL) improves survival for adults newly diagnosed with the disease.
|
|
|
Cancer News
|
Scientists 'supercharge' cancer-fighting T cells
|
10 March 2022, ScienceDaily
|
Scientists have identified a way to 'supercharge' tumor-attacking T cells, a finding that may not only improve the effectiveness of a promising type of cell-based cancer immunotherapy but also expand the number of cancers it can treat...
|
|
|
|
|
|
|
|
|
|
|
� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|